Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9873 - 9880 of 12085 results
Privacy Monday - January 19, 2015: New Additions to Mintz's Privacy & Security Group
January 19, 2015| Blog| Viewpoint
Who is “Disabled” under ABLE?
January 19, 2015| Blog| Viewpoint
New Funding for Energy Innovation: D.O.E. Announces $125 Million for Transformational Energy Projects
January 16, 2015| Blog| Viewpoint
Four Things to Know About the 2015 SEC OCIE Exam Priorities
January 16, 2015| Blog| Viewpoint
FDA Proposes to Apply Risk-Based Framework to Accessory Devices
January 16, 2015| Blog| Viewpoint
You're Invited: Tips for Surviving a HIPAA Audit
January 16, 2015| Blog| Viewpoint
ConAgra Foods Defeats Challenge to Its Executive Exemption Classification in FLSA Class Action
January 15, 2015| Blog| Viewpoint
Bully for You: Ready or Not, California’s Anti-Bullying Training Requirement Starts Now
January 15, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|